Literature DB >> 17702850

Induction of CXCL1 by extracellular matrix and autocrine enhancement by interleukin-1 in rat pancreatic beta-cells.

Pascale Ribaux1, Jan A Ehses, Nathalie Lin-Marq, Fabio Carrozzino, Marianne Böni-Schnetzler, Eva Hammar, Jean-Claude Irminger, Marc Y Donath, Philippe A Halban.   

Abstract

As we showed previously, the extracellular matrix (ECM) derived from rat bladder carcinoma cells (804G-ECM) has positive effects on rat primary beta-cell function and survival in vitro. The aim of this study was to define beta-cell genes induced by this ECM with a specific focus on cytokines. Analysis of differential gene expression by oligonucleotide microarrays, RT-PCR, and in situ hybridization was performed to identify cytokine mRNA induced by this matrix. Four cytokines were overexpressed on 804G-ECM compared with poly-L-lysine: C-X-C motif ligand 1 (CXCL1), CXCL2, interferon-inducible protein-10, and IL-1beta. A time-course experiment indicated that maximal induction by 804G-ECM of CXCL1/2 and interferon-inducible protein-10 occurred at 4 h. Stimulation of CXCL1 release by beta-cells on 804G-ECM was confirmed at the protein level. Moreover, secreted CXCL1 was shown to be functionally active by attracting rat granulocytes. Preventing the interaction of beta1 integrins and laminin-5 (a major component of 804G-ECM) with specific antibodies resulted in a 40-50% inhibition of CXCL1 expression. Using the nuclear factor-kappaB pathway inhibitor Bay 11-7082 it is demonstrated that CXCL1 expression and secretion are dependent on nuclear factor-kappaB activation. IL-1 secreted by beta-cells plated on 804G-ECM was found to be a key soluble mediator because treatment of cells with the IL-1 receptor antagonist significantly reduced both CXCL1 gene expression and secretion. It is concluded that ECM induces expression of cytokines including CXCL1 with amplification by IL-1 acting via a positive autocrine feedback loop.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17702850     DOI: 10.1210/en.2007-0325

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  19 in total

1.  Macrophage migration inhibitory factor deficiency protects pancreatic islets from cytokine-induced apoptosis in vitro.

Authors:  I Stojanovic; T Saksida; I Nikolic; F Nicoletti; S Stosic-Grujicic
Journal:  Clin Exp Immunol       Date:  2012-08       Impact factor: 4.330

2.  Signaling pathways implicated in the stimulation of beta-cell proliferation by extracellular matrix.

Authors:  Géraldine Parnaud; Eva Hammar; Pascale Ribaux; Marc Y Donath; Thierry Berney; Philippe A Halban
Journal:  Mol Endocrinol       Date:  2009-05-14

3.  Transcriptional regulation of CXC-ELR chemokines KC and MIP-2 in mouse pancreatic acini.

Authors:  Lidiya S Orlichenko; Jaideep Behari; Tzu-Hsuan Yeh; Shiguang Liu; Donna B Stolz; Ashok K Saluja; Vijay P Singh
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-07-29       Impact factor: 4.052

4.  Short term exposure of beta cells to low concentrations of interleukin-1β improves insulin secretion through focal adhesion and actin remodeling and regulation of gene expression.

Authors:  Caroline Arous; Pedro G Ferreira; Emmanouil T Dermitzakis; Philippe A Halban
Journal:  J Biol Chem       Date:  2015-01-13       Impact factor: 5.157

5.  Extracellular factors and immunosuppressive drugs influencing insulin secretion of murine islets.

Authors:  V J Auer; E Janas; V Ninichuk; E Eppler; T S Weiss; S Kirchner; A M Otto; M J Stangl
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

6.  TLR2/6 and TLR4-activated macrophages contribute to islet inflammation and impair beta cell insulin gene expression via IL-1 and IL-6.

Authors:  Dominika Nackiewicz; Meixia Dan; Wei He; Rosa Kim; Anisa Salmi; Sabine Rütti; Clara Westwell-Roper; Amanda Cunningham; Madeleine Speck; Carole Schuster-Klein; Beatrice Guardiola; Kathrin Maedler; Jan A Ehses
Journal:  Diabetologia       Date:  2014-05-12       Impact factor: 10.122

7.  Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation.

Authors:  Marianne Böni-Schnetzler; Jeffrey Thorne; Géraldine Parnaud; Lorella Marselli; Jan A Ehses; Julie Kerr-Conte; Francois Pattou; Philippe A Halban; Gordon C Weir; Marc Y Donath
Journal:  J Clin Endocrinol Metab       Date:  2008-07-29       Impact factor: 5.958

8.  CD40 activation in human pancreatic islets and ductal cells.

Authors:  D Klein; F Timoneri; H Ichii; C Ricordi; R L Pastori
Journal:  Diabetologia       Date:  2008-07-26       Impact factor: 10.122

9.  The lysine deacetylase inhibitor Givinostat inhibits β-cell IL-1β induced IL-1β transcription and processing.

Authors:  Mattias S Dahllöf; Dan P Christensen; Morten Lundh; Charles A Dinarello; Paolo Mascagni; Lars G Grunnet; Thomas Mandrup-Poulsen
Journal:  Islets       Date:  2012 Nov-Dec       Impact factor: 2.694

10.  Silencing mitogen-activated protein 4 kinase 4 (MAP4K4) protects beta cells from tumor necrosis factor-alpha-induced decrease of IRS-2 and inhibition of glucose-stimulated insulin secretion.

Authors:  Karim Bouzakri; Pascale Ribaux; Philippe A Halban
Journal:  J Biol Chem       Date:  2009-08-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.